QSMetric Potential Indications – Parkinson disease Discover a potential indication of QSMetric™ technology. Dr ROCHE Stéphane Parkinson’s disease is a neurodegenerative disorder caused by the formation of a-synuclein protein aggregates in neurons and their death. Associated with this aggregation is …
Potential Indications – Alzheimer’s and related diseases Discover a potential indication of advanced technology of magnetic susceptibility. Dr ROCHE Stéphane Alzheimer’s disease is a progressive neurodegenerative disorder affecting various brain regions. The pathophysiological process involves an accumulation of Aβ peptides …
Potential Indications [Context] Iron, iron accumulation and ferroptosis Dr ROCHE Stéphane Background to our series of articles “Biomedical applications of advanced technology of magnetic susceptibility” Intracerebral iron is involved in the formation and maintenance of neuronal networks and is essential …
Committed to a quality approach involving information security management, Ventio has decided to follow the ISO 27001 standard, considered to be the benchmark in this field. Noémie Vang is a certified ‚Lead Implementer‘, enabling the formal implementation of this standard …
Stephane Roche becomes CEO of Ventio Technical Director for the past 2 years, Dr Stephane Roche took up his new position as Chief Executive Officer of Ventio at the end of April 2024. This appointment recognises the work of a …
Imaging services at the cutting edge of innovation and with very high added value In March 2024 issue, “La Jaune & La Rouge” magazine interviewed our CEO Ludovic de Rochefort about Ventio’s expertise, the importance of sharing healthcare data to …
New recruit at Ventio to strengthen IT system security Hello Anis, welcome! You joined the team a few weeks ago already. In order to get to know you better and understand your missions at Ventio, we invite you to answer …
Following its participation in Journées Francophones de Radiologie 2023, Ventio presents its services, vision and ethics. Using biomedical imaging with innovative biomarkers to help identify new therapeutic targets, help diagnose brain diseases, treat patients earlier and improve their follow-up. Ventio …
Les marqueurs biologiques protéiques du liquide céphalorachidien : caractéristiques et implications cliniques dans les démences A Gabelle, S. Roche & S Lehmann Revue Neurologique, Volume 165, Issue 3, March 2009, Pages 213-222 Résumé : L’exactitude du diagnostic dans le champ …
Auto-antibody profiling on high-density protein microarrays for biomarker discovery in the cerebrospinal-fluid. Stéphane Roche, Yves Dauvilliers, Laurent Tiers, Carine Couderc, Marie-Thérèse Piva, Monique Provansal, Audrey Gabelle & Sylvain Lehmann Journal of Immunological Methods, Volume 338, Issues 1–2, 30 September 2008, …
Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field Ludovic de Rochefort, Ryan Brown, Martin R. Prince, Yi Wang Magnetic Resonance in Medecine, First published: 24 September 2008 Abstract Magnetic properties characterized by susceptibility and chemical …
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers Stéphane Roche, Audrey Gabelle & Sylvain Lehmann Proteomics Clin Appl. 2008 Mar;2(3):428-36. Abstract : The cerebrospinal fluid (CSF) circulates within the CNS where it plays an essential physiological …